Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 1,367 | 1,085 | 2,056 | 1,859 | 2,256 |
| Cost of Goods | 1,100 | 879 | 1,890 | 1,655 | 2,134 |
| Gross Profit | 267 | 206 | 166 | 204 | 123 |
| Operating Expenses | 2,132 | 1,460 | 1,564 | 1,116 | 2,184 |
| Operating Income | -1,765 | -375 | -508 | -257 | -1,928 |
| Interest Expense | 34 | 51 | 68 | 62 | 84 |
| Other Income | 404 | -19 | -65 | -34 | 58 |
| Pre-tax Income | -1,394 | -445 | -640 | -354 | -1,954 |
| Net Income Continuous | -1,395 | -445 | -640 | -354 | -1,949 |
| Minority Interests | 4 | -42 | -17 | 29 | -24 |
| Net Income | $-1,399 | $-403 | $-623 | $-383 | $-1,935 |
| EPS Basic Total Ops | -0.08 | -0.02 | -0.04 | -0.03 | -0.07 |
| EPS Basic Continuous Ops | -0.08 | -0.03 | -0.04 | -0.02 | -0.07 |
| EPS Diluted Total Ops | -0.08 | -0.02 | -0.04 | -0.03 | -0.07 |
| EPS Diluted Continuous Ops | -0.08 | -0.03 | -0.04 | -0.02 | -0.07 |
| EBITDA(a) | $-1,484 | $-232 | $-359 | $-101 | $-1,604 |